Cargando…

Korean Medication Algorithm for Depressive Disorders 2017: Third Revision

OBJECTIVE: In 2002, the Korean Society for Affective Disorders developed the guidelines for the treatment of major depressive disorder (MDD), and revised it in 2006 and 2012. The third revision of these guidelines was undertaken to reflect advances in the field. METHODS: Using a 44-item questionnair...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Jeong Seok, Bahk, Won-Myong, Wang, Hee Ryung, Woo, Young Sup, Park, Young-Min, Jeong, Jong-Hyun, Kim, Won, Shim, Se-Hoon, Lee, Jung Goo, Jon, Duk-In, Min, Kyung Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810446/ https://www.ncbi.nlm.nih.gov/pubmed/29397669 http://dx.doi.org/10.9758/cpn.2018.16.1.67

Ejemplares similares

Korean Medication Algorithm Project for Bipolar Disorder: third revision
por: Woo, Young Sup, et al.
Publicado: (2015)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2017)

Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision
por: Woo, Young Sup, et al.
Publicado: (2018)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
por: Jang, Seung-Ho, et al.
Publicado: (2023)

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary
por: Seo, Jeong Seok, et al.
Publicado: (2021)

Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary
por: Woo, Young Sup, et al.
Publicado: (2022)

Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2019)

Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
por: Wang, Hee Ryung, et al.
Publicado: (2014)

Effect of Initial Ziprasidone Dose on Treatment Outcome of Korean Patients with Acute Manic or Mixed Episodes
por: Woo, Young Sup, et al.
Publicado: (2011)

The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines
por: Woo, Young Sup, et al.
Publicado: (2022)

Prevalence of bipolar spectrum disorder in Korean college students according to the K-MDQ
por: Bae, Seung Oh, et al.
Publicado: (2013)

Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines
por: Jeong, Jong-Hyun, et al.
Publicado: (2023)

Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Corrigendum: Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder Among Adults and Children/Adolescents in Korea
por: Seo, Jeong-Cheol, et al.
Publicado: (2022)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Psychometric Properties of the Hypomania Checklist-32 in Korean Patients with Mood Disorders
por: Yoon, Bo-Hyun, et al.
Publicado: (2017)

Screening with the Korean Version of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents: Korean Validity and Reliability Study
por: Shim, Se-Hoon, et al.
Publicado: (2018)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Improving the Screening Instrument of Bipolar Spectrum Disorders: Weighted Korean Version of the Mood Disorder Questionnaire
por: Hong, Narei, et al.
Publicado: (2018)

Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors
por: Shim, In Hee, et al.
Publicado: (2017)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

PS150. Comparative efficacy of various augmentation strategies for treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Wang, Hee Ryung, et al.
Publicado: (2016)

The Impact of COVID-19 on Psychiatric Health in the Korean Population
por: Wang, Sheng-Min, et al.
Publicado: (2023)

Clinical assessment of bipolar depression: validity, factor structure and psychometric properties of the Korean version of the Bipolar Depression Rating Scale (BDRS)
por: Jung, Young-Eun, et al.
Publicado: (2016)

Prevalence and Comorbidities of Adult Attention-deficit/ hyperactivity Disorder in a Community Sample from Korea
por: Woo, Young Sup, et al.
Publicado: (2023)

Validation of the Korean Version of the Depression in Old Age Scale and Comparison with Other Depression Screening Questionnaires Used in Elderly Patients in Medical Settings
por: Jung, Young-Eun, et al.
Publicado: (2019)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
por: Song, Hoo Rim, et al.
Publicado: (2015)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

Factors associated with bullying victimization among Korean adolescents
por: Seo, Hye-Jin, et al.
Publicado: (2017)

The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire
por: Wang, Hee Ryung, et al.
Publicado: (2020)

Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials
por: Wang, Hee Ryung, et al.
Publicado: (2015)

The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
por: Choi, Won-Seok, et al.
Publicado: (2022)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

Psychometric Properties of the Korean Version of Functioning Assessment Short Test in Bipolar Disorder
por: Kang, Hangoeunbi, et al.
Publicado: (2023)

Dose Trends of Aripiprazole from 2004 to 2014 in Psychiatric Inpatients in Korea
por: Woo, Young Sup, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_97v8dog08a248j4ut72pdt1jrt